Clinical and Experimental Ophthalmology · 2010 · 30 citations · 15 references
PharmacyOphthalmologySurgeryOcular Drug DeliveryOphthalmic Drug DeliveryOphthalmic SurgeryAnterior Segment Drug DeliveryCorneal Drug DeliveryMydriatic AgentsOphthalmic SolutionsTopical Ocular Drug DeliveryTopical Ophthalmic MedicationsDrug Delivery To The EyeIntracameral AnesthesiaIntracameral InjectionMydriatic Drug ActionPharmacologic MydriasisPreoperative MydriasisTopical Mydriatic AgentsTopical Ophthalmic Formulations
BACKGROUND: This study investigated the efficacy and safety of intracameral injection of commercially available eye drops containing 0.5% tropicamide and 0.5% phenylephrine hydrochloride (Mydrin-P, Santen Pharmaceutical, Osaka, Japan). DESIGN: In vitro experiment and prospective clinical study at a private hospital. PARTICIPANTS AND SAMPLES: Mydrin-P was applied to confluent cultured human corneal endothelial cells, and the cellular morphology was examined. Clinical study subjects were 65 eyes of 65 patients that underwent phaco-emulsification and aspiration with intraocular lens implantation and received intracameral injection of Mydrin-P for poor mydriasis after preoperative topical instillation of mydriatics (intraocular mydriasis group; with five subgroups based on cause: diabetes, pseudo-exfoliation, post-surgery, uveitis, unknown). Controls, comprising 39 eyes of 39 patients, were not injected with Mydrin-P. METHODS: The ratio of pupillary diameter to corneal diameter was determined before and after injection of Mydrin-P. Corneal endothelial density was measured preoperatively and 3 months and 1 year postoperatively. MAIN OUTCOME MEASURES: Pupillary diameter and corneal endothelial density. RESULTS: Human corneal endothelial cell morphology was unaltered after Mydrin-P injection. The mean ratio of the pupillary diameter to corneal diameter increased in the intraocular mydriasis group (before: 54.2 ± 4.8%, after: 58.4 ± 6.6%; P < 0.001) and in the diabetes and unknown subgroups. The corneal endothelial cell density reduction rate 3 months and 1 year after surgery was not significantly different between the intraocular mydriasis group and controls. CONCLUSION: Intracameral injection of Mydrin-P appears to be effective and safe for dilating the pupil in cases with poor mydriasis after preoperative instillation of mydriatics.
15
Risk Factors for Intraoperative Complications in 1000 Extracapsular Cataract Cases
James P. Guzek, Martin Blomhoff Holm, John B. Cotter et al. · Ophthalmology · 1987 · 228 citations
Medicine, Ophthalmology, Surgery +11
Effect of Donor Age on Morphologic Variation of Cultured Human Corneal Endothelial Cells
Kazunori Miyata, Jonathan Drake, Yasuhiro Osakabe et al. · Cornea · 2001 · 122 citations